Ipamorelin/CJC-DAC Blend

Also known as: Ipa/CJC-DAC, Long-Acting GH Blend

Ipamorelin (ghrelin mimetic) + CJC-1295 with DAC (extended GHRH); provides sustained GH elevation over days due to DAC albumin binding.

Typical dose: 1 mg – 2 mg
Frequency: twice weekly
Route: Subcutaneous
Half-life: 8 days
Routes: Subcutaneous
Status: Research chemical (compounded blend)

Track your Ipamorelin/CJC-DAC Blend protocol in Vial →

Benefits

Sustained GH elevation
Less frequent dosing
Improved body composition
Better sleep

Dosing

A common research range for Ipamorelin/CJC-DAC Blend is 1 mg to 2 mg twice weekly. 2mg twice weekly; DAC extends half-life to ~8 days. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.

Reconstitution

A typical reconstitution for Ipamorelin/CJC-DAC Blend is 5 mg of peptide in 2.5 mL of bacteriostatic water, giving roughly 2 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.

Half-life

Ipamorelin/CJC-DAC Blend has an approximate half-life of 8 days. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.

Storage

2-8°C post-reconstitution.

Reported side effects

Water retention
Tingling/numbness
Joint pain
Hunger increase

Contraindications

Active cancer
Pituitary disorders
Uncontrolled diabetes

Track Ipamorelin/CJC-DAC Blend with Vial

Vial logs every Ipamorelin/CJC-DAC Blend dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →

This page is for educational and harm-reduction purposes only. Ipamorelin/CJC-DAC Blend is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.